T1 diabetes, Libre expert. Award-Winning diabetes advocate. Insight Analyst, MBA/MSc Business Analytics. Choral musician.
Birmingham
Joined January 2009
- Tweets9.1K
- Following1.7K
- Followers2.2K
- Likes8.9K
I'm officially half an Attenborough as it's my fiftieth today! Having a quick pint before heading off to do some singing. Not quite the Albert Hall but will certainly do!
Excellent concert tonight @batonflipper with @TheCBSO. Have graduated from bringing children to a family concert you conducted years ago to now coming to see my son singing his first concert as a member of the @CBSOChorus #proud
Nick Cahm retweeted
Don’t Forget. Applications for diabetes research grants up to £12,000 from the Novo Nordisk UK Research Foundation close this Friday 12 December. apply at nnukrf.org.uk
@drpratikc @RichardIGHolt @ShareenForbes
Nick Cahm retweeted
The ABCD-NNUKRF 2026 3 year Research Fellowship for HCPs working in diabetes in the UK is open for applications until 7 Jan. Up to £300k. Go to abcd.care/current/research-f… for application forms. @ABCDiab @drpratikc @ShareenForbes @RichardIGHolt
An in person event. At a @BT1DUK Discovery Day with the first speaker being @GlucoseNLies.
Nick Cahm retweeted
Up to £300,000 available for UK HCPs wanting to do a 3 year PhD in diabetes starting in 2026. Joint funding from ABCD and NNUKRF. Deadline 7 Jan. Info and application forms abcd.care/current/research-f… @ABCDiab @drpratikc @ShareenForbes @RichardIGHolt
Nick Cahm retweeted
Diabetes researchers can apply for small Research Grants up to £12,000 from the Novo Nordisk UK Research Foundation. Deadline 12 December. nnukrf.org.uk for details and application forms. @drpratikc @ShareenForbes @RichardIGHolt
Nick Cahm retweeted
All funding opportunities for diabetes HCPs based in the UK now open for applications inc: research, education and a research fellowship funded joint with ABCD.
Search nnukrf.org.uk or abcd.care . @ABCDiab @drpratikc @ShareenForbes @RichardIGHolt
Nick Cahm retweeted
*NEWS*
For the #T1Diabetes community!!
Yes, THAT event is back 😊
@TADtalkEvents
Courtesy @Rezaidi @nerdabetic @AdrianLong3 @Type1Adventures @ellierosehuckle
#TAD2025 - in #Liverpool
Another day of fun, camaraderie, stories, laughter and maybe even some tears
Come and be a part of this event - and/or share with others in your groups or clinics
Ticket numbers are capped, so please apply as soon as possible to avoid missing out!
#gbdoc 💙
Link to Register:
docs.google.com/forms/d/e/1F…
Nick Cahm retweeted
It’s a BEAUTIFUL thing
Also to all with #T1D and using technology?
A reminder that THIS weekend…the Clocks go FORWARD 😊
Do make the changes as needed!
And love you all for the kindness & warmth x💙
An inspirational day for the AGM and Fellow presentations as part of my new trustee role of the @NNUKRF. Excellent work presented in a compelling way by all the Fellows, with the prospect of improved outcomes and better understanding of various diabetes-related issues. @drpratikc
Freestyle Libre 3 with integrated ketone monitoring in the pipeline. A new insight into ketones needed due to low awareness of DKA amongst PWT1D and resistance or lack of knowledge of when ketone testing desirable. Hoping this is just the start of multi-analyte sensing. #ATTD2025
Leicester and @drpratikc (with his "sexy beard"!) leading the way with HCL rollout. Over 350 starts in 9 months with over half being direct changes from mdi. Results achieved in line with clinical trials. Progress is happening and happening quickly. #ATTD2025
Nick Cahm retweeted
The power of the patient voice: The Libre saga -Nick Cahm
Must-have for a successful engagement in #diabetes management:
▪️ Education
▪️Motivation
▪️ Support
▪️ Tech
#ATTD2025 #dedoc° #NothingAboutUsWithoutUs @ATTDconf #diabetes #PayItForward
Nick Cahm retweeted
For those at #ATTD2025 - either as a #dedoc voice or otherwise - would be good to get information on @TandemDiabetes for roll out of devices, new sets and updates to CIQ UK/EU. Tandem said last year that Mobi would be 2nd half 2025, but would need an app released. Any updates?
Abbott ATTD symposium starts with explanation that there is no proper standard for CGMs and MARD is a flawed assessor (as highlighted by @Tims_Pants and others). Moving to a new iCGM method in the US and an equivalent EU standard is required and a consensus is sought. #ATTD2025